Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory D Lewis

Showing results (251-260 of 270) with videos related to

Pageof 27
Sort By:
Journal of the American Heart Association|October 8, 2024
Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory DeathJoyce C Zhou, Meghan E Sise, Kamila Drezek, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 9, 2025
A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart TransplantationFrederick M Lang, Guilherme Marmontel Nasi, Julia Allen, et al.
Nature Medicine|October 29, 2021
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialMichael E Nassif, Sheryl L Windsor, Barry A Borlaug, et al.
Journal of the American College of Cardiology|September 10, 2021
Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art ReviewAmbarish Pandey, Sanjiv J Shah, Javed Butler, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2019
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label studyEmily D Bethea, Kerry Gaj, Jenna L Gustafson, et al.
JACC. Heart Failure|November 30, 2023
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study DesignCaroline J Coats, Martin S Maron, Theodore P Abraham, et al.
Circulation|April 7, 2026
Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection FractionIsabela Landsteiner, Lindsey K Stolze, Tess E Peterson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 23, 2021
Matrix Gla Protein Levels Are Associated With Arterial Stiffness and Incident Heart Failure With Preserved Ejection FractionRajeev Malhotra, Christopher J Nicholson, Dongyu Wang, et al.
The European Respiratory Journal|November 27, 2024
Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research CollaborationGabor Kovacs, Marc Humbert, Alexander Avian, et al.
The New England Journal of Medicine|September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic CardiomyopathyPablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
Pageof 27

Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
Journal of the American Heart Association|October 8, 2024
Early Renal Outcomes Following Heart Transplantation Using Organs Procured After Circulatory DeathJoyce C Zhou, Meghan E Sise, Kamila Drezek, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 9, 2025
A Perioperative Blood Conservation Protocol to Achieve Successful Bloodless Heart TransplantationFrederick M Lang, Guilherme Marmontel Nasi, Julia Allen, et al.
Nature Medicine|October 29, 2021
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialMichael E Nassif, Sheryl L Windsor, Barry A Borlaug, et al.
Journal of the American College of Cardiology|September 10, 2021
Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art ReviewAmbarish Pandey, Sanjiv J Shah, Javed Butler, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2019
Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label studyEmily D Bethea, Kerry Gaj, Jenna L Gustafson, et al.
JACC. Heart Failure|November 30, 2023
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study DesignCaroline J Coats, Martin S Maron, Theodore P Abraham, et al.
Circulation|April 7, 2026
Multi-Organ Physiologic Deficits During Exercise Identify Clinical and Molecular Predisposition to Heart Failure with Preserved Ejection FractionIsabela Landsteiner, Lindsey K Stolze, Tess E Peterson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 23, 2021
Matrix Gla Protein Levels Are Associated With Arterial Stiffness and Incident Heart Failure With Preserved Ejection FractionRajeev Malhotra, Christopher J Nicholson, Dongyu Wang, et al.
The European Respiratory Journal|November 27, 2024
Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research CollaborationGabor Kovacs, Marc Humbert, Alexander Avian, et al.
The New England Journal of Medicine|September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic CardiomyopathyPablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
Pageof 27